FDA Approves TECNIS PureSee IOL for Cataract Surgery

First FDA-approved extended depth of focus (EDOF) IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL

March 23, 2026
2 min

The Ophthalmologist

Share

Johnson & Johnson has received FDA approval for TECNIS PureSee IOL, an innovative extended depth of focus intraocular lens designed for cataract surgery. This lens aims to enhance the visual experience for patients with cataracts, addressing not only cataract-related vision loss, but also the effects of presbyopia. Available later this year, the TECNIS PureSee IOL promises to offer high contrast sensitivity, minimizing reliance on glasses post-surgery, as revealed by positive patient feedback.